Clinical Trial Update: Sphenopalatine Ganglion Blockade in Migraine [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on sphenopalatine ganglion blockade for episodic migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Episodic Migraine

Snippet

Sponsor: Afyonkarahisar Health Sciences University | Conditions: Episodic Migraine | Phase 3 | Status: UNKNOWN